tu.adeyemi
Submits third-party assay reports on material purchased directly. Based in Tampere.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
8
n=8
Annotations
0
n=0
Median purity submitted
99.28%
n=8
Suppliers covered
5
n=8
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042879 | MK-677 (Ibutamoren mesylate) | GGPeps | GGPE-2509-T2530 | Nordanalyt | 2026-Q1 | 99.61 | 4.26 | — | Supplier-supplied | 1 | FAIL |
| AX-2025-019723 | L-Glutathione (reduced) | HJ | HJ-2507-P3062 | Janoshik | 2025-Q4 | 99.27 | 6.51 | 94.0 | Supplier-supplied | 0 | PASS |
| AX-2025-018869 | TB-500 | QSC | QSC-2505-B8934 | Janoshik | 2025-Q3 | 99.66 | 4.10 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020643 | MOTS-c | SSA | SSA-2503-S7755 | Medutest | 2025-Q3 | 99.29 | 4.65 | 104.3 | Buyer-sourced | 0 | PASS |
| AX-2025-018737 | Semaglutide | QSC | QSC-2412-F7396 | VendorInvestigate | 2025-Q2 | 97.41 | 2.96 | 101.1 | Buyer-sourced | 1 | MARGINAL |
| AX-2025-019777 | TB-500 | HJ | HJ-2501-A3383 | Kestrel | 2025-Q1 | 99.55 | 5.17 | — | Supplier-supplied | 2 | FAIL |
| AX-2024-005476 | Tirzepatide | BCH | BCH-2407-F6722 | Medutest | 2024-Q4 | 97.51 | 5.19 | 103.1 | Supplier-supplied | 2 | MARGINAL |
| AX-2024-005021 | Semaglutide | GGPeps | GGPE-2405-P2227 | Janoshik | 2024-Q3 | 98.78 | 3.57 | — | Supplier-supplied | 1 | MARGINAL |